42 Publikationen
-
2023 | Zeitschriftenaufsatz | PUB-ID: 2980346Changes in diagnosing giant cell arteritis of the temporal artery over a 7.7 year periodPUB
Röchter M, Thiesbrummel S, Marchi H, Fuchs C, Rudwaleit M (2023)
Annals of the Rheumatic Diseases 82(1579). -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2983818Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2PUB | DOI | WoS
Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Giger S, Marzo OH, et al. (2023)
In: Abstracts of the Annual meeting of theSwiss Society of Rheumatology. Swiss Medical Weekly, 153(Suppl. 271). Basel: EMH Schweizerischer Ärzteverlag: 23S. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2984578Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the Phase 3 studies BE MOBILE 1 and BE MOBILE 2PUB | DOI | WoS
Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Sarno A, Marzo-Ortega H, et al. (2023)
In: Abstract Supplement - 39th Scandinavian Congress of Rheumatology. Scandinavian Journal of Rheumatology , 52(Suppl. 131). Abingdon: Taylor & Francis : 73-74. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984077Patient-reported-Outcomes bei Vaskulitispatienten in Deutschland – Daten aus dem KOBRA-QualitätsprojektPUB | DOI | WoS
Löffler C, Rudwaleit M, Lakomek H-J, Stammann C, Hellmich B (2023)
Zeitschrift für Rheumatologie. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2982993Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritisPUB | DOI | PubMed | Europe PMC
Rudwaleit M, Machado PM, Taieb V, de Peyrecave N, Hoepken B, Gensler LS (2023)
Therapeutic Advances in Musculoskeletal Disease 15. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982790Long-term clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis stratified by baseline MRI and c-reactive protein statusPUB | DOI | WoS
Zochling J, Robinson PC, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2023)
Internal Medicine Journal 53(Suppl. 1): 25. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982783Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic DrugsPUB | DOI | WoS
Rudwaleit M, Morup M, Humphries B, Zannat NE, Willems D, Taieb V, Boonen A (2023)
Value in Health 26(6 Suppl.): S397. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982796Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 StudiesPUB | WoS
Bird P, Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, de la Loge C, Ellis A, Fleurinck C, et al. (2023)
Internal Medicine Journal 53(S2): 24-25. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968373 PUB | DOI | WoS | PubMed | Europe PMC
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968910Nachruf der Deutschen Gesellschaft für Rheumatologie (DGRh) auf den Träger der Kussmaul-Medaille der DGRh Prof. Dr. Ernst FeldtkellerPUB | DOI | WoS | PubMed | Europe PMC
Braun J, Rudwaleit M, Sieper J, Specker C (2023)
Zeitschrift für Rheumatologie. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968388Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trialsPUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, et al. (2023)
Annals of the Rheumatic Diseases. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2969537Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled StudiesPUB | DOI | WoS
Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, de la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, et al. (2022)
In: ISPOR Europe 2022 Abstracts. Value in Health, 25(12, Suppl.). New York: Elsevier : S427-S428. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968210Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception CohortPUB | DOI | WoS
Torgutalp M, Rios-Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2946-2948. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968211Comparison of Established and New, Preliminarily Proposed ASAS Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints of Axial Spondyloarthritis Patients and Implications for Recruitment in Clinical StudiesPUB | DOI | WoS
Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1997-2000. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968213Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc AnalysisPUB | DOI | WoS
Brandt-Juergens J, Rudwaleit M, Behrens F, Ritchlin C, Peterlik D, Quebe-Fehling E, Calheiros R, Deodhar A (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2074-2076. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968219Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled StudyPUB | DOI | WoS
Deodhar A, van der Heijde D, Gensler L, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1101-1105. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968220ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial SpondyloarthritisPUB | DOI | WoS
Diekhoff T, Eshed I, Giraudo C, Haibel H, Hermann K-G, de Hooge M, Jans L, Jurik A, Lambert RG, Machado P, Maksymowych WP, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Reumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 788-790. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968222ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 UpdatePUB | DOI | WoS | PubMed | Europe PMC
Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewe R, Van den Bosch F, Boteva B, Bremander A, Carron P, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022 ,November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1094-1097. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968218Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 StudiesPUB | DOI | WoS
Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, De la Loge C, Ellis A, Fleurinck C, Oortgiesen M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatolgy (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 810-813. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968217MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial SpondyloarthritisPUB | DOI | WoS
Maksymowych WP, Ostergaard M, Baraliakos X, Machado P, Pedersen SJ, Weber U, Eshed I, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 4490-4492. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968216Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled StudiesPUB | DOI | WoS
Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 814-816. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968215An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial SpondyloarthritisPUB | DOI | WoS
Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compan V, Tham R, Kumke T, Bauer L, Kim M, Gensler L (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1097-1100. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968214Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein StatusPUB | DOI | WoS
Robinson PC, Maksymowych WP, Gensler L, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 808-810. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966738MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSIONPUB | DOI | WoS
Navarro-Compan V, Rudwaleit M, De Peyrecave N, Fleurinck C, Oortgiesen M, Taieb V, Baraliakos X (2022)
Annals of the Rheumatic Diseases 81(Suppl. 1): 771-772. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966741TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IS ASSOCIATED WITH RETARDATION OF RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORTPUB | DOI | WoS
Torgutalp M, Rodriguez VR, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 14-15. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966746LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUSPUB | DOI | WoS
Robinson P, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 774-775. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966748BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDYPUB | DOI | WoS
Deodhar A, Van der Heijde D, Gensler LS, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 772-773. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2965259Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception CohortPUB | DOI | WoS | PubMed | Europe PMC
Torgutalp M, Rodriguez VR, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
Arthritis & Rheumatology . -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2963951Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritisPUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
Torgutalp M, Rios Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
Annals of the rheumatic diseases 81(9): 1252-1259. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2964357Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd StudyPUB | DOI | WoS | PubMed | Europe PMC
Robinson PC, Maksymowych WP, Gensler LS, Hall S, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, de Peyrecave N, Deodhar A (2022)
ACR Open Rheumatology. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2963700MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working groupPUB | DOI | WoS | PubMed | Europe PMC
Baraliakos X, Ostergaard M, Lambert RG, Eshed I, Machado PM, Pedersen SJ, Weber U, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, et al. (2022)
Annals of the Rheumatic Diseases. -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2962214Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd studyPUB | DOI | WoS | PubMed | Europe PMC
van der Heijde D, Gensler LS, Maksymowych WP, Landewe R, Rudwaleit M, Bauer L, Kumke T, Kim M, Auteri SE, Hoepken B, Deodhar A (2022)
RMD Open 8(1): e002138. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961894Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?PUB | DOI | WoS
Baraliakos X, Rodriguez VR, Torgutalp M, Dilbaryan A, Haibel H, Verba M, Sieper J, Braun J, Rudwaleit M, Poddubnyy D (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 319-321. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961900Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial SpondyloarthritisPUB | DOI | WoS
Maksymowych W, Lambert R, Baraliakos X, Pedersen S, Eshed I, Weber U, Machado P, De Hooge M, Sieper J, Wichuk S, Poddubnyy D, et al. (2021)
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1878-1880. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961899Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal?PUB | DOI | WoS
Maksymowych W, Weber U, Baraliakos X, Machado P, Pedersen S, Sieper J, Wichuk S, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe R, et al. (2021)
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1876-1878. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961897Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter StudyPUB | DOI | WoS
van der Heijde D, Gensler L, Maksymowych W, Landewe R, Rudwaleit M, Bauer L, Hoepken B, Kumke T, Kim M, Deodhar A (2021)
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1896-1899. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961896Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc AnalysisPUB | DOI | WoS
Magrey M, Ramiro SA, Pinheiro MM, Gao T, Ganz F, Song I-H, Biljan A, Haroon N, Rudwaleit M (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 1931-1933. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961895Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial SpondyloarthritisPUB | DOI | WoS
Rudwaleit M, Machado P, Gensler L, Taieb V, de Peyrecave N, Hoepken B, van der Heijde D (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 734-738. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961892Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception CohortPUB | DOI | WoS
Torgutalp M, Rodriguez VR, Verba M, Protopopov M, Proft F, Rademacher J, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 931-933. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961881Association of the improvement of Synovitis and Enthesitis with quality of life/patient reported outcomes in patients with PsA treated with IxekizumabPUB | DOI | WoS
Kristensen LE, McGonagle D, Rudwaleit M, Kameda H, Holzkaemper T, El Baou C, Smolen J (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 3722-3724. -
2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2959486Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegolPUB | DOI | WoS | PubMed | Europe PMC
Maksymowych WP, Kumke T, Auteri SE, Hoepken B, Bauer L, Rudwaleit M (2021)
Arthritis Research and Therapy 23(1): 274. -
2021 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2958359Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in DeutschlandPUB | DOI | WoS | PubMed | Europe PMC
Kiltz U, Buschhorn-Milberger V, Albrecht K, Lakomek H-J, Lorenz H-M, Rudwaleit M, Schneider M, Schulze-Koops H, Aringer M, Hasenbring MI, Herzer P, et al. (2021)
Zeitschrift fur Rheumatologie.